Guías
Uso de Racional de Antibióticos: Mecanismos de Resistencia y su Impacto Clínico
J Antimicrob Chemother 2001; 48(Suppl 1): 87-102 8. Livermore DM. Of Pseudmonas, porins, pumps and carbapenems. J Antimicrob Chemother 2001; 47: 241-50. 9. Moritz, VA, Carsson PB. Cefoxitin sensitivity as a marker for inducible beta-lactamases. J Med Microbiol 1986; 21: 203-7. 10. Nordmann, P. Trends in ß-lactam resistance in Enterobacteriaceae: Clin Infect Dis 1998; 27(Suppl 1): S100-6. 11. Sanders, CC, Sanders We Jr. ß-lactam resistance in Gram-negative bacteria: global trends and clinical impact. Clin Infect Dis 1992; 15:824-839. 12. Sanabria O, Diaz P, Ovalle MV, Agudelo CI, Castañeda E. Adult invasive isolates of Streptococcus pneumoniae in Colombia: Surveillance of capsular types and antimicrobial susceptibility (1995-2000). Abstracts of the 1st International Symposium on Antimicrobial Resistance; Cartagena, Colombia. 2001; 38. 13. Teng, LJ, Hsueh PR, Chen YC, Ho SW, Luh KT: Antimicrobial susceptibility of viridans group streptococci in Taiwan with an emphasis on the high rates of resistance to penicillin and macrolides in Streptococcus oralis. J Antimicrob Chemother 1998; 41: 621-7. Autor: FUNDACION SANTAFE DE BOGOTA
<< Pgina Anterior
Pgina Siguiente >>
[Pgina 1] [Pgina 2] [Pgina 3] [Pgina 4] [Pgina 5] [Pgina 6] [Pgina 7] [Pgina 8]
|